Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles
Authors:
- 1 May 1997
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (5) , 966-970
Abstract
Objective. Transglutaminases (TGases) (E.G. 2.3.2.13) catalyze a posttranslational modification of proteins and are associated with biomineralization in growth plate cartilage. Type II TGase participates in the activation of latent transforming growth factor β (TGFß), a crucial factor for both normal cartilage mineralization and the pathologic mineralization that results in calcium pyrophosphate dihydrate (CPPD) crystal formation in aging articular cartilage. To explore a possible association between TGase levels and CPPD crystal formation in mature articular cartilage, TGase activity in articular chondrocytes from old and young pigs and in the articular cartilage vesicle (ACV) fraction of porcine articular cartilage was examined. In addition, the effects of TGase inhibitors on the production of inorganic pyrophosphate (PPi), a process necessary for CPPD crystallogenesis, were determined.Methods. TGase activity was measured with a radiometric assay in cultured articular chondrocytes from the knee joints of old (3–5 years old) and young (2–6 weeks old) pigs and in the ACVs. PPi levels were measured in chondrocyte‐conditioned media in the presence of TGase inhibitors or control compounds.Results. Levels of TGase activity in the cytosolic fraction of old chondrocytes were 7‐fold higher than those in identically cultured young chondrocytes. The mean ± SD activity level in the membrane fraction of lysed chondrocytes was 6.0 ± 0.6 units/mg protein in old articular chondrocytes and was undetectable in young chondrocytes. In ACVs, the mean ± SD TGase activity level was 1.23 ± 0.1 units/mg protein. Type II TGase protein was present in chondrocyte cytosol and in ACVs. TGase activity was increased by TGFß to 120% of control values (P < 0.01), and decreased by insulin‐like growth factor 1 to 80% of control values (P < 0.01). TGase inhibitors blocked media accumulation of PPi, an essential precursor of CPPD crystal formation, and a sensitive marker of TGFß effect.Conclusion. These data suggest a potential link between TGase activity and processes of pathologic biomineralization that result in CPPD crystal formation in aging articular cartilage.Keywords
This publication has 13 references indexed in Scilit:
- Transglutaminase activity in rabbit articular chondrocytes in cultureBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
- Tissue Transglutaminase: A Candidate Effector Element of Physiological Cell Death1995
- Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3.Journal of Biological Chemistry, 1994
- Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor β1-stimulated chondrocytes and cartilageOsteoarthritis and Cartilage, 1994
- Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.Journal of Cell Biology, 1993
- Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes.Journal of Cell Biology, 1993
- Articular Cartilage Vesicles Generate Calcium Pyrophosphate Dihydrate‐Like Crystals in VitroArthritis & Rheumatism, 1992
- Transforming growth factor β1 stimulates inorganic pyrophosphate elaboration by porcine cartilageArthritis & Rheumatism, 1991
- A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity.Journal of Biological Chemistry, 1990
- TransglutaminasesMolecular and Cellular Biochemistry, 1984